Acute interventions

Stroke

Volumn 28, Issue 7, 1997, Pages 1518-1521

  Pessin, Michael S ^a   Adams Jr , Harold P ^a   Adams, Robert J ^a   Fisher, Marc ^a   Furlan, Anthony J ^a   Hacke, Werner ^a   Haley Jr , E Clarke ^a   Hazinski, Mary Fran ^a   Helgason, Cathy M ^a   Higashida, Randall T ^a   Koroshetz, Walter ^a   Marler, John R ^a   Ornato, Joseph P ^a  

^a NONE

Author keywords

AHA Medical Scientific Statements; Angioplasty; Prevention; Stroke; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANTICOAGULANT AGENT; ANTIOXIDANT; ANTITHROMBOCYTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; FIBRINOLYTIC AGENT; GLYCINE RECEPTOR ANTAGONIST; HEPARIN; HEPARINOID; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; LOW MOLECULAR WEIGHT HEPARIN; LUBELUZOLE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NALMEFENE; NEUROPROTECTIVE AGENT; NIMODIPINE; SODIUM CHANNEL BLOCKING AGENT; TIRILAZAD;

ACUTE DISEASE; ANGIOPLASTY; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONFERENCE PAPER; FIBRINOLYTIC THERAPY; HEALTH CARE SYSTEM; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; REIMBURSEMENT; STENT; CEREBROVASCULAR DISEASE; TREATMENT OUTCOME;

ACUTE DISEASE; CEREBROVASCULAR DISORDERS; HUMANS; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 0031178723     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.28.7.1518     Document Type: Conference Paper

References (17)

1. Adams HP Jr, Brott TG, Crowell RM, Furlan AJ, Gomez CR, Grotta J, Helgason CM, Marier JR, Woolson RF, Zivin JA, Feinberg W, Mayberg M. Guidelines for the management of patients with acute ischemic stroke: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1994;25:1901-1914.
2. Adams HP Jr, Brott TG, Furlan AJ, Gomez CR, Grotta J, Helgason CM, Kwiatkowskj T, Lyden PD, Marler JR, Torner J, Feinberg W, Mayberg M, Thies W. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Stroke. 1996;94: 1167-1174.
3. Boysen G, Pessin MS. Thrombolytic therapy. In: Bogousslavsky J, Ginsberg M, eds. Cerebrovascular Disease: Pathology, Diagnosis, and Management. Malden, Mass: Blackwell Science; 1997.
4. Feinberg WM, Albers GW, Barnett HJM, Biller J, Caplan LR, Carter LP, Hart RG, Hobson RW II, Kronmal RA, Moore WS, Robertson JT. Guidelines for the management of transient ischemic attacks: from the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks of the Stroke Council of the American Heart Association. Stroke. 1994;25:1320-1335.
5. Sherman DG, Dyken ML Jr, Gent M, Harrison JG, Hart RG, Mohr JP. Antithrombotic therapy for cerebrovascular disorders: an update. Chest. 1995;108(suppl):444S-456S.
6. Adams HP Jr, Woolson RF, Clarke WR, et al. Design of the trial of ORG 10172 in acute stroke treatment (TOAST): implications for other trials of treatments of persons with acute ischemic stroke. Control Clin Trials. 1996.
7. Silver B, Weber J, Fisher M. Medical therapy for ischemic stroke. Clin Neuropharmacol. 1996;19:101-128.
8. Higashida RT, Tasi FY, Halbach W, Dowd CF, Hieshima GB. Transluminal angioplasty, thrombolysis, and stenting for extracranial and intracranial cerebral vascular disease. Journal of Interventional Cardiology. 1996;9. In press.
9. Rogers WJ, Bowlby LJ, Chandra NC, French WJ, Gore JM, Lambren CT, Rubison RM, Tiefenbrunn AJ, Weaver WD. Treatment of myocardial infarction in the United States (1990 to 1993): observations from the National Registry of Myocardial Infarction. Circulation. 1994;90:2103-2114.
10. Kereiakes DJ, Weaver WD, Anderson JL, Feldman T, Gibler B, Aufderheide T, Williams DO, Martin LH, Anderson LC, Martin JS, et al. Time delays in the diagnosis and treatment of acute myocardial infarction: a tale of eight cities. Report from the Prehospital Study Group and the Cincinnati Heart Project. Am Heart J. 1990;120:773-780.
11. Lyden PD, Rapp K, Babcock T, et al. Ultra-rapid identification, triage and enrollment of stroke patients into clinical trials. Journal of Stroke and Cerebrovascular Diseases. 1994;2:106-113.
12. Kothari R, Hall K, Broderick J, Brott T. Early stroke recognition: a prehospital stroke scale. Stroke. 1996;27:171. Abstract.
13. Indredavik B, Bakke F, Solberg R, Rokseth R, Haaheim LL, Holme I. Benefit of a stroke unit: a randomized controlled trial. Stroke. 1991;22:1026-1031.
14. Adams RJ, Fisher M, Furlan AJ, del Zoppo G. Acute stroke treatment trials in the United States: rethinking strategies for success. Stroke. 1995;26:2216-2218.
15. De Haan R, Horn J, Limburg M, Van Der Meulen J, Bossuyt P. A comparison of five stroke scales with measures of disability, handicap, and quality of life. Stroke. 1993;24:1178-1181.
16. Baron JC, von Kummer R, del Zoppo GJ. Treatment of acute ischemic stroke: challenging the concept of a rigid and universal time window. Stroke. 1995;26:2219-2221.
17. Paczynski R, Hsu CY, Diringer MN. Pathophysiology of ischemic injury. In: Fisher M, ed. Stroke Therapy. Boston, Mass: Butterworth-Heinemann; 1995:29-64.